封面
市場調查報告書
商品編碼
1844074

按服務類型、照護類型、用途和病患狀況分類的臨終關懷市場—全球預測,2025-2032年

Hospice Market by Service Type, Care Type, Application, Patient Condition - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,臨終關懷市場規模將達到 2,408.2 億美元,複合年成長率為 8.04%。

關鍵市場統計數據
基準年 2024 1296.7億美元
預計年份:2025年 1395.9億美元
預測年份 2032 2408.2億美元
複合年成長率 (%) 8.04%

關注不斷發展的臨終關懷生態系統,明確臨床重點、營運韌性、勞動力動態和政策壓力之間的交集。

臨終關懷行業正經歷曲折點,其特徵是人口結構的變化、護理偏好的演變以及支付方和提供方日益成長的財務壓力。近年來,隨著老齡化社會慢性病和近期疾病的盛行率上升,人們對富有同情心、多學科的臨終關懷服務的需求增加,同時也暴露了人力資源和醫療服務基礎設施方面的機構性限制。

臨床醫生和管理人員正在透過重新配置診療路徑、投資互通技術以及探索融合居家照護和機構護理的混合服務模式來適應變化。同時,支付方和監管機構也在重新思考報銷框架和品質指標,以便更好地獎勵那些體現以病人為中心的目標的醫療成果。這種各方力量的匯聚既為相關人員帶來了風險,也帶來了機遇,他們需要在臨床卓越性和營運韌性之間取得平衡。

本導言透過強調需要製定整合策略來建立後續分析組裝,該策略應涵蓋臨床服務、供應鏈完整性、員工隊伍永續性和監管協調等面向。讀者將發現基於實證的整合方法,這些方法可為實際決策提供支持,幫助領導者優先考慮各項干預措施,以在提升組織靈活性的同時,維持醫療品質。

變革力量正在重塑臨終關懷服務,包括擴大數位化照護、重新設計勞動力結構、增強供應鏈韌性以及以結果主導的報銷獎勵。

臨終關懷的格局正在發生變化,這需要在臨床、營運和財務等領域進行策略調整。科技的普及加速了遠距症狀管理和虛擬看護者支援的發展,促使醫療服務提供者將遠端醫療和數位監測納入傳統的照護計畫。這些進步在改善農村和醫療資源匱乏地區患者獲得臨終關懷服務的同時,也正在改變資源分配和人員配備模式。

同時,勞動市場動態變化也帶來了持續的壓力。招募難題、職業倦怠以及對專業安寧療護訓練的需求,正促使各機構重新設計職缺並加大對人才留任策略的投入。政策和支付改革日益將報銷與患者報告的療效和護理連續性指標掛鉤,這鼓勵了整合式護理路徑的構建以及居家護理和機構護理服務之間的跨領域協調。

近期全球動盪暴露了關鍵醫療用品和耐用消費品採購的脆弱性,使得供應鏈韌性成為一項策略要務。因此,醫療機構正在尋求供應商多元化,盡可能將生產外包到近岸地區,並建立庫存控制機制,以避免醫療服務中斷。鑑於這些變革,領導者必須採取適應性策略,在創新、嚴格的臨床管治和永續營運模式之間取得平衡。

關稅累積主導的醫療進口壓力促使臨終關懷供應鏈各環節進行策略採購調整、採購流程重組和成本協同削減。

影響進口醫療設備和耗材的關稅政策正對臨終關懷機構及其供應鏈造成多層次的成本和營運影響。累積的關稅壓力推高了某些醫療設備、一次性耗材和生產投入品的到岸成本,進而影響了居家照護和機構照護的籌資策略。這些壓力正沿著分銷網路層層傳遞,促使採購方重新評估供應商合約、庫存緩衝和總體擁有成本分析。

為此,許多醫療系統和獨立臨終關懷機構正在加快採購多元化步伐,盡可能納入國內製造商,並對未受關稅上漲影響地區的替代供應商進行資格審核。雖然這些戰術性調整降低了對單一來源的依賴,但通常需要投入資金進行檢驗、員工培訓和物流重組。此外,由於採購團隊需要將關稅調整後的成本方案和關稅減免條款納入供應商契約,融資週期也隨之延長。

政策的不確定性也促使支付方和系統層級就成本控制和報銷調整展開策略性對話。一些醫療機構正在透過增加採購合作和集團採購安排來重新獲得議價能力,而其他機構則在重新設計診療路徑,以減少對定價產品的依賴,同時又不影響臨床療效。最終,價格動態動態的累積效應將加速整個臨終關懷生態系統在採購、合約簽訂和庫存管治的結構性變革。

細分市場對臨床設計、人員配備模式和供應鏈的影響,涵蓋服務類型、護理環境、用途和不同的患者群體。

細分市場層面的動態變化揭示了不同的需求促進因素和業務要務,因此需要針對每項服務組合和患者群體採取客製化的方法。服務類型包括諮詢、醫療用品、護理和醫生服務,每種服務在人員配備、資格認證和品質保證方面都有不同的需求。諮詢服務著重於心理社會介入和看護者支持體系,而醫療用品服務則需要強大的庫存管理和物流夥伴關係關係。護理服務需要可擴展的人員配備模式和基於能力的症狀管理培訓,而醫生服務則專注於臨床監督、複雜症狀管理和跨學科協調。

目錄

第1章:序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將遠端醫療和遠端患者監護解決方案整合到臨終關懷服務模式中
  • 文化勝任護理課程對不同人口群體的重要性日益凸顯
  • 基於價值的報銷模式的實施將影響醫療服務提供者的財務永續性。
  • 擴大小兒科服務範圍,以滿足末期兒童的特殊需求
  • 將人工智慧工具應用於個人化症狀管理和預測分析
  • 借助先進的行動醫療設備技術,居家照護的使用日益增多
  • 臨終關懷機構與社區組織建立夥伴關係,以加強全面支持服務。
  • 監管變革將推動整個護理行業品質指標和報告要求的標準化。
  • 一項新的專案計劃著重於為家庭看護者提供喪親支持和心理健康服務。
  • 採用電子健康記錄互通性標準將簡化不同醫療機構之間的護理協調。

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章:按服務類型分類的臨終關懷市場

  • 諮詢服務
  • 醫療用品服務
  • 護理服務
  • 醫師服務

第9章:按護理類型分類的臨終關懷市場

  • 持續居家照護
  • 普通住院護理
  • 住院短期照顧
  • 日常居家護理

第10章 按應用分類的臨終關懷市場

  • 機構護理
    • 臨終關懷中心
    • 醫院
    • 專業護理機構
  • 居家照護

第11章 以病人病情分類的臨終關懷市場

  • 癌症患者
  • 心血管疾病
  • 慢性腎臟病
  • 愛滋病毒/愛滋病
  • 神經系統疾病
  • 呼吸系統疾病

第12章 按地區分類的臨終關懷市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 按集團分類的臨終關懷市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國臨終關懷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣,2024
  • 競爭分析
    • AccentCare, Inc.
    • Agape Care Group
    • Amedisys, Inc.
    • Amvis Holdings, Inc.
    • BAYADA Home Health Care
    • Care24 Pvt Ltd.
    • Community Hospice & Palliative Care
    • Compassus
    • Dierksen Hospice
    • Elara Caring
    • Enhabit, Inc.
    • Envision Healthcare Holdings, Inc
    • Gateway Hospice & Palliative Care
    • Genesis Healthcare, Inc.
    • Gentiva
    • Heart to Heart Hospice
    • Hope Hospice Inc.
    • Humana Inc.
    • Interim HealthCare Inc
    • Jeevodaya Hospice
    • LHC GROUP, INC.
    • Lifepath Hospice Care Services
    • Option Care Health Inc.
    • Sage Hospice Holdings, LLC
    • St Andrew's Hospice
    • Traditions Health, LLC
    • Trustbridge, Inc
    • VITAS Healthcare by Chemed Corporation
Product Code: MRR-CA17E905E7ED

The Hospice Market is projected to grow by USD 240.82 billion at a CAGR of 8.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 129.67 billion
Estimated Year [2025] USD 139.59 billion
Forecast Year [2032] USD 240.82 billion
CAGR (%) 8.04%

A focused orientation to the evolving hospice ecosystem, defining the intersection of clinical priorities, operational resilience, workforce dynamics, and policy pressures

The hospice sector is navigating an inflection point defined by demographic shifts, evolving care preferences, and intensified fiscal pressures across payers and providers. In recent years, the prevalence of chronic, life-limiting conditions among aging populations has increased demand for compassionate, multidisciplinary end-of-life care while simultaneously exposing systemic constraints in workforce capacity and supply infrastructure.

Clinicians and administrators are adapting by reconfiguring care pathways, investing in interoperable technologies, and exploring hybrid service models that blend home-based and facility-based care. At the same time, payers and regulators are revisiting reimbursement frameworks and quality metrics to better reward outcomes that reflect patient-centered goals. These converging forces create both risk and opportunity for stakeholders who can align clinical excellence with operational resilience.

This introduction frames the subsequent analysis by highlighting the need for integrated strategies that address clinical delivery, supply chain integrity, workforce sustainability, and regulatory alignment. Readers will find an evidence-informed synthesis designed to support pragmatic decisions, enabling leaders to prioritize interventions that preserve care quality while strengthening organizational agility.

Transformative forces reshaping hospice delivery including digital care expansion, workforce redesign, supply chain resilience, and outcome-driven reimbursement incentives

The landscape of hospice care is shifting in ways that demand strategic recalibration across clinical, operational, and financial domains. Technological diffusion has accelerated remote symptom management and virtual caregiver support, prompting providers to embed telehealth and digital monitoring within traditional care plans. These advances are improving access for patients in rural and underserved communities while also changing resource allocation and staffing models.

Concurrently, workforce dynamics are exerting sustained pressure: recruitment challenges, burnout, and the need for specialized palliative training are prompting organizations to redesign roles and invest in retention strategies. Policy and payment reforms are increasingly linking reimbursement to patient-reported outcomes and care continuity metrics, which incentivizes integrated care pathways and cross-setting coordination between home-based and facility-based services.

Supply chain resilience has become a strategic imperative after recent global disruptions exposed vulnerabilities in sourcing critical medical supplies and durable equipment. As a result, providers are expanding supplier diversification, nearshoring procurement where feasible, and establishing inventory governance to avoid care interruptions. Taken together, these transformative shifts require leaders to pursue adaptive strategies that balance innovation with rigorous clinical governance and sustainable operational models.

Cumulative tariff-driven pressures on medical imports prompting strategic sourcing shifts, procurement redesign, and collaborative cost-mitigation across hospice supply chains

Tariff policies affecting imported medical equipment and supplies have introduced a layered set of cost and operational implications for hospice providers and their supply chains. Cumulative tariff pressures contribute to higher landed costs for certain devices, disposable supplies, and manufacturing inputs, which in turn affect procurement strategies across both home-based and facility-based care settings. These pressures have propagated through distribution networks, prompting buyers to reassess supplier contracts, inventory buffers, and total cost of ownership analyses.

In response, many health systems and standalone hospice operators have accelerated diversification of sourcing to include domestic manufacturers where feasible and to qualify alternative suppliers in regions not subject to elevated duties. This tactical pivot reduces single-source exposure but often requires investments in validation, staff training, and logistics reconfiguration. Additionally, capital procurement timelines have lengthened as purchasing teams incorporate tariff-adjusted cost scenarios and tariff mitigation clauses within supplier agreements.

Policy uncertainty has also catalyzed strategic conversations at the payer and system level about cost containment and reimbursement alignment. Some providers are layering procurement collaboratives and group purchasing arrangements to regain negotiating leverage, while others are redesigning care pathways to limit reliance on tariff-exposed goods without compromising clinical outcomes. Ultimately, the cumulative effect of tariff dynamics is to accelerate structural change in sourcing, contracting, and inventory governance across the hospice ecosystem.

Segment-specific implications for clinical design, staffing models, and supply chains across service types, care settings, applications, and diverse patient condition cohorts

Segment-level dynamics reveal differentiated demand drivers and operational imperatives that require tailored approaches across service portfolios and patient cohorts. Based on Service Type, the landscape spans counselling services, medical supply services, nursing services, and physician services, each with distinct staffing, credentialing, and quality assurance imperatives. Counselling services emphasize psychosocial interventions and caregiver support frameworks, while medical supply services demand robust inventory controls and logistics partnerships. Nursing services require scalable staffing models and competency-based training for symptom management, and physician services focus on clinical oversight, complex symptom control, and interdisciplinary coordination.

Based on Care Type, providers must align resource intensity with care setting needs across continuous home care, general inpatient care, inpatient respite care, and routine home care. Continuous home care emphasizes intensive nursing and rapid-response capabilities, general inpatient care centers on acute symptom stabilization within licensed facilities, inpatient respite care provides temporary relief for caregivers, and routine home care addresses longitudinal symptom monitoring and routine visits. These care types drive differences in workforce scheduling, documentation protocols, and emergency escalation pathways.

Based on Application, the continuum includes facility-based care and home-based care. Facility-based care subdivides into hospice centers, hospitals, and skilled nursing facilities, each presenting unique regulatory environments, capital demands, and coordination challenges with community providers. Home-based care requires investments in mobile technology, remote monitoring, and caregiver education to ensure safe transitions. Finally, based on Patient Condition, service design must be sensitive to the needs of cancer patients, those with cardiovascular diseases, chronic kidney disease, HIV/AIDS, neurological disorders, and respiratory diseases. Clinical protocols, medication management, and palliative interventions must be adapted to the symptomatic profiles and prognostic trajectories associated with these conditions, while care teams integrate specialty consultations and advance care planning to optimize comfort and dignity.

Regional differentiation across the Americas, Europe Middle East & Africa, and Asia-Pacific that requires tailored clinical models, procurement strategies, and workforce planning

Regional heterogeneity shapes both opportunity and operational risk in hospice delivery, requiring geographically attuned strategies for service expansion and resilience. In the Americas, demographic aging in many jurisdictions is increasing demand for community-based and home-centered hospice services, while urban-rural divides challenge access to specialized palliative care. Regulatory frameworks and payer arrangements vary significantly across federal and subnational jurisdictions, which influences provider contracting strategies, licensure requirements, and cross-border partnerships. Consequently, organizations operating in this region must prioritize scalable telehealth capabilities and workforce deployment models that can flex between densely populated and remote service areas.

Across Europe, Middle East & Africa, diverse health system maturities and financing mechanisms create a mosaic of needs. In higher-income markets, there is growing emphasis on quality metrics, patient-reported outcomes, and integrated care pathways; in emerging markets, basic access to trained palliative clinicians and essential medicines remains a dominant priority. Cultural expectations around end-of-life care also shape family involvement and service design, requiring culturally sensitive engagement strategies and community education initiatives. Meanwhile, public-private collaborations and philanthropic partnerships can play an outsized role in capacity building and training in this region.

The Asia-Pacific region is characterized by rapid demographic transitions, urbanization, and an expanding middle class that is driving demand for both facility-based and home-based hospice services. Workforce constraints are acute in several countries, intensifying the need for task-shifting, telehealth integration, and community health worker training to extend palliative reach. Cross-border supply chains and regional manufacturing hubs influence procurement strategies, and regulatory harmonization efforts offer potential opportunities for scalable service models across multiple jurisdictions. In each region, success depends on aligning clinical models with local payer rules, cultural norms, and supply chain realities while leveraging technology to bridge access gaps.

Competitive and collaborative corporate behaviors driving consolidation, capability investment, and integrated care platforms to strengthen hospice market positioning

Competitive dynamics among organizations operating in the hospice space are being reshaped by consolidation, vertical integration, and a focus on capability-based differentiation. Leading providers are investing in clinical centers of excellence, advanced training for palliative clinicians, and interoperable platforms that enable seamless transitions between home-based and facility-based care. Supplier ecosystems are responding by developing bundled service offerings, remote monitoring solutions, and logistics services that are specifically optimized for end-of-life care needs.

Strategic alliances between payers and providers are also emerging, with some entities piloting alternative payment structures tied to patient experience and continuity of care. These collaborations incentivize investments in care coordination teams, data analytics to track outcomes, and enhanced caregiver support programs. Healthcare technology vendors are differentiating through integrated platforms that combine electronic medical records, telehealth, and remote symptom monitoring, while service organizations enhance capabilities in bereavement counselling and caregiver education to increase both clinical value and brand trust.

Smaller and regional operators compete by emphasizing local community ties, cultural competence, and nimble operational models that can adapt quickly to regulatory or supply chain disruptions. Across the landscape, the ability to demonstrate clinical quality, operational reliability, and cost-effective integration across settings is becoming the key determinant of long-term competitive advantage.

Practical recommendations for procurement resilience, workforce sustainability, digital enablement, care pathway redesign, and payer-provider partnerships to secure hospice performance

Leaders should prioritize a set of actionable measures that balance immediate operational resilience with medium-term strategic positioning. First, optimize procurement by diversifying supplier bases and negotiating contract terms that include tariff mitigation clauses and flexible delivery. Strengthen inventory governance and adopt performance-based supplier scorecards to maintain continuity of critical medical supplies.

Second, invest in workforce sustainability through targeted retention programs, competency-based palliative training, and role redesign that enables efficient task allocation between registered clinicians and ancillary staff. Embed mental health supports and professional development pathways to reduce turnover and enhance care quality. Third, accelerate digital enablement by scaling telehealth for symptom management, deploying remote monitoring where clinically appropriate, and integrating electronic health records to reduce fragmentation across home-based and facility-based care settings. These investments should be paired with clear data governance and interoperability plans.

Fourth, redesign care pathways that align with differentiated segments: calibrate staffing and resource intensity across continuous home care, general inpatient care, inpatient respite, and routine home care to match patient needs and avoid unnecessary escalation. Tailor clinical protocols for major patient condition cohorts, ensuring that disease-specific symptom management and advance care planning are standardized and measurable. Finally, pursue strategic partnerships with payers, manufacturers, and community organizations to pilot value-based arrangements, expand access, and share clinical data that supports outcome-based reimbursement models. Together, these recommendations create a pragmatic roadmap for sustaining high-quality, economical hospice care.

Methodological overview describing stakeholder engagement, qualitative triangulation, scenario-based analysis, and ethical safeguards underpinning the hospice sector insights

This research synthesizes qualitative and quantitative inputs from provider interviews, supplier assessments, regulatory reviews, and secondary literature to derive actionable insights. Primary stakeholder engagement included clinical leaders, procurement executives, and policy advisors who provided contextualized perspectives on operational challenges and innovation adoption. Inputs were triangulated with public regulatory guidance, clinical practice standards, and observable procurement behaviors to validate themes and identify adoption barriers.

Analytical approaches combined thematic content analysis with scenario-based stress testing of supply chain and workforce variables to ensure conclusions remain robust across plausible operational conditions. Careful attention was paid to ethical considerations in data handling, and all primary interviews were conducted under protocols that protect confidentiality and professional anonymity. Methodological limitations are acknowledged where data access constrained granularity, and recommendations are therefore framed to emphasize strategic orientation and operational levers rather than prescriptive metrics.

Integrated conclusion emphasizing the need for coordinated action across procurement, digital capability, workforce development, and payer collaboration to fortify hospice care

The hospice sector stands at a strategic crossroads where demographic demand, technological opportunity, workforce limits, and policy evolution intersect. The imperative for leaders is to convert insight into integrated action: reinforcing supply chain resilience, adopting pragmatic digital tools that extend clinical capacity, and redesigning care pathways to match patient complexity across home-based and facility-based settings. Equally important is the need to invest in workforce development and retention, because the human element remains the core of high-quality end-of-life care.

Organizations that proactively align procurement strategy, clinical governance, and payer engagement will be better positioned to absorb external shocks and deliver consistent, compassionate care. The cumulative picture is one of transformation rather than disruption: those who pursue deliberate, evidence-informed change can create more resilient and patient-centered hospice systems that sustain quality while adapting to economic and policy headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of telehealth and remote patient monitoring solutions in hospice services delivery models
  • 5.2. Growing emphasis on culturally competent hospice care programs for diverse demographic groups
  • 5.3. Implementation of value based reimbursement models impacting hospice provider financial sustainability
  • 5.4. Expansion of pediatric hospice services tailored to the unique needs of terminally ill children
  • 5.5. Incorporation of artificial intelligence tools for personalized symptom management and predictive analytics
  • 5.6. Increase in home based hospice care utilization supported by advanced mobile medical equipment technologies
  • 5.7. Collaborative partnerships between hospice providers and community organizations to enhance holistic support services
  • 5.8. Regulatory changes driving standardization of quality metrics and reporting requirements in hospice care sector
  • 5.9. Emerging specialized programs focusing on bereavement support and mental health for hospice family caregivers
  • 5.10. Adoption of electronic health record interoperability standards to streamline hospice care coordination across settings

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hospice Market, by Service Type

  • 8.1. Counselling Services
  • 8.2. Medical Supply Services
  • 8.3. Nursing Services
  • 8.4. Physician Services

9. Hospice Market, by Care Type

  • 9.1. Continuous Home Care
  • 9.2. General Inpatient Care
  • 9.3. Inpatient Respite Care
  • 9.4. Routine Home Care

10. Hospice Market, by Application

  • 10.1. Facility-based Care
    • 10.1.1. Hospice Center
    • 10.1.2. Hospitals
    • 10.1.3. Skilled Nursing Facility
  • 10.2. Home-based Care

11. Hospice Market, by Patient Condition

  • 11.1. Cancer Patients
  • 11.2. Cardiovascular Diseases
  • 11.3. Chronic Kidney Disease
  • 11.4. HIV/AIDS
  • 11.5. Neurological Disorders
  • 11.6. Respiratory Diseases

12. Hospice Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hospice Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hospice Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. AccentCare, Inc.
    • 15.3.2. Agape Care Group
    • 15.3.3. Amedisys, Inc.
    • 15.3.4. Amvis Holdings, Inc.
    • 15.3.5. BAYADA Home Health Care
    • 15.3.6. Care24 Pvt Ltd.
    • 15.3.7. Community Hospice & Palliative Care
    • 15.3.8. Compassus
    • 15.3.9. Dierksen Hospice
    • 15.3.10. Elara Caring
    • 15.3.11. Enhabit, Inc.
    • 15.3.12. Envision Healthcare Holdings, Inc
    • 15.3.13. Gateway Hospice & Palliative Care
    • 15.3.14. Genesis Healthcare, Inc.
    • 15.3.15. Gentiva
    • 15.3.16. Heart to Heart Hospice
    • 15.3.17. Hope Hospice Inc.
    • 15.3.18. Humana Inc.
    • 15.3.19. Interim HealthCare Inc
    • 15.3.20. Jeevodaya Hospice
    • 15.3.21. LHC GROUP, INC.
    • 15.3.22. Lifepath Hospice Care Services
    • 15.3.23. Option Care Health Inc.
    • 15.3.24. Sage Hospice Holdings, LLC
    • 15.3.25. St Andrew's Hospice
    • 15.3.26. Traditions Health, LLC
    • 15.3.27. Trustbridge, Inc
    • 15.3.28. VITAS Healthcare by Chemed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOSPICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HOSPICE MARKET SIZE, BY CARE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HOSPICE MARKET SIZE, BY CARE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOSPICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HOSPICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOSPICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS HOSPICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL HOSPICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HOSPICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. HOSPICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. HOSPICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HOSPICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HOSPICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HOSPICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HOSPICE MARKET SIZE, BY COUNSELLING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HOSPICE MARKET SIZE, BY MEDICAL SUPPLY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HOSPICE MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HOSPICE MARKET SIZE, BY PHYSICIAN SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HOSPICE MARKET SIZE, BY CONTINUOUS HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HOSPICE MARKET SIZE, BY GENERAL INPATIENT CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HOSPICE MARKET SIZE, BY INPATIENT RESPITE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HOSPICE MARKET SIZE, BY ROUTINE HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HOSPICE MARKET SIZE, BY HOSPICE CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HOSPICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HOSPICE MARKET SIZE, BY SKILLED NURSING FACILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HOSPICE MARKET SIZE, BY HOME-BASED CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HOSPICE MARKET SIZE, BY CANCER PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HOSPICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HOSPICE MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HOSPICE MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HOSPICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HOSPICE MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOSPICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HOSPICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS HOSPICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS HOSPICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL HOSPICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL HOSPICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 241. GCC HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GCC HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GCC HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. GCC HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. GCC HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GCC HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. GCC HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. GCC HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 250. GCC HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 251. GCC HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 252. GCC HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 274. BRICS HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 275. BRICS HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 276. BRICS HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 277. G7 HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. G7 HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. G7 HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. G7 HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. G7 HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. G7 HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. G7 HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. G7 HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. G7 HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 286. G7 HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 287. G7 HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 288. G7 HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 289. NATO HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NATO HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. NATO HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. NATO HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. NATO HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NATO HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. NATO HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NATO HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NATO HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 298. NATO HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 299. NATO HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 300. NATO HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL HOSPICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL HOSPICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED STATES HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED STATES HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 311. UNITED STATES HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED STATES HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 321. CANADA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 322. CANADA HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. MEXICO HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. MEXICO HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. MEXICO HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 330. MEXICO HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 331. MEXICO HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 332. MEXICO HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 333. BRAZIL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. BRAZIL HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. BRAZIL HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. BRAZIL HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. BRAZIL HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. BRAZIL HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. BRAZIL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 340. BRAZIL HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 341. BRAZIL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 342. BRAZIL HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 343. UNITED KINGDOM HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED KINGDOM HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. UNITED KINGDOM HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED KINGDOM HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. UNITED KINGDOM HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. UNITED KINGDOM HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. UNITED KINGDOM HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 350. UNITED KINGDOM HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 351. UNITED KINGDOM HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 352. UNITED KINGDOM HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 353. GERMANY HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. GERMANY HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 355. GERMANY HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. GERMANY HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 357. GERMANY HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. GERMANY HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 359. GERMANY HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 360. GERMANY HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 361. GERMANY HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 362. GERMANY HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 363. FRANCE HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. FRANCE HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 365. FRANCE HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 366. FRANCE HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 367. FRANCE HOSPICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 368. FRANCE HOSPICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 369. FRANCE HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2018-2024 (USD MILLION)
  • TABLE 370. FRANCE HOSPICE MARKET SIZE, BY FACILITY-BASED CARE, 2025-2032 (USD MILLION)
  • TABLE 371. FRANCE HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2018-2024 (USD MILLION)
  • TABLE 372. FRANCE HOSPICE MARKET SIZE, BY PATIENT CONDITION, 2025-2032 (USD MILLION)
  • TABLE 373. RUSSIA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. RUSSIA HOSPICE MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 375. RUSSIA HOSPICE MARKET SIZE, BY CARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 376. RUSSIA HOSPICE MARKET SIZE, BY CARE TYPE, 2025-2032 (USD MILLION)

TABLE 377.